January 1, 2010Thrombosis and Haemostasis
Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at ‘moderate risk’ CHADS2 score=1: Simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice
Key result
Anticoagulation therapy simplifies stroke risk assessment and thromboprophylaxis in real-life clinical practice for patients with atrial fibrillation at moderate risk (CHADS2 score=1).
Authors
Discussion
Loading...
Member takes
Implication
May guide anticoagulation in moderate-risk AF; leaves open need for randomized confirmation.
Key Points
Key points are not available for this paper at this time.
Cite This Study
Gregory Y.H. Lip (2010) studied this question. Anticoagulation therapy simplifies stroke risk assessment and thromboprophylaxis in real-life clinical practice for patients with atrial fibrillation at moderate risk (CHADS2 score=1).